← Back to Company DatabaseVisit Website
Tempus
AI-driven precision medicine platform for cancer care.
PublicChicago, ILFounded 2015
About
Tempus is a technology company that has built one of the largest libraries of clinical and molecular data to enable personalized cancer treatment. Its platform uses AI to analyze clinical and genomic data, helping physicians make data-driven treatment decisions. The company also partners with pharmaceutical companies for drug development and clinical trial matching.
Total Funding
$1.3BKey Product
Tempus xT genomic profiling and AI analytics platformGeography
North AmericaKey Investors
NEARevolution GrowthBaillie Gifford
Focus Areas
Data / AnalyticsAI / Machine LearningDiagnostics
Technology
AI / Machine LearningGenomics / SequencingDigital Health / Software
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026